Boehringer Ingelheim
This website is for UK Healthcare Professionals. If you are a patient or member of the public please visit our public website here
Find adverse event reporting information at the bottom of this page
Contact
Boehringer Ingelheim
Boeringer Ingelheim
Boehringer Ingelheim
Boeringer Ingelheim
Boehringer Ingelheim
Boeringer Ingelheim
  • Diseases

    Diseases

    • Diseases
    • Asthma
    • Chronic Heart Failure (CHF)
    • Chronic Kidney Disease (CKD)
    • COPD
    • Dermatology
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Progressive Pulmonary Fibrosis (PPF)
    • Stroke
    • Type 2 Diabetes
  • Products

    Products

    • Products
    • JARDIANCE® (empagliflozin)
    • METALYSE 25 mg (tenecteplase)
    • OFEV® (nintedanib)

    • SPEVIGO (spesolimab)
    • SPIOLTO® Respimat® (tiotropium/olodaterol)
    • SPIRIVA® Respimat® (tiotropium)
    • TRAJENTA® (linagliptin)
  • Resources

    Resources

    • Resources
      • Healthcare Professional Resources
      • Cardio Renal Metabolism
      • Respiratory
  • Click here to join
    our mailing list to hear
    news & updates about our products     Opens in new tab
  • Find adverse event reporting information at the bottom of this page
  • Contact
Boeringer Ingelheim
SPIOLTO Respimat (tiotropium + olodaterol) inhaler with cartridge and green lid, and SPIRIVA Respimat (tiotropium) inhaler with cartridge and blue lid
Logo of the SPIRIVA Respimat (tiotropium) and SPIOLTO Respimat (tiotropium + olodaterol) inhalation solution

Respiratory resources

  • Respiratory Hub
  • Respiratory resources

SPIRIVA® Respimat® (tiotropium) is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year. SPIRIVA Respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD).

SPIOLTO® Respimat (tiotropium + olodaterol) is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD.

Quick link

  • Prescribing Information Opens in new tab

Reset all filters
Close-up of a man holding and using the Respimat inhaler

Video

5:11 m
  • Preparing the Respimat for first use
  • Daily use of the Respimat
  • Respimat inhaler cartridge exchange
  • Respimat inhaler replacement

Respimat how-to-use summary

Opens in new tab
Cover image for 'Respimat how to use summary' PDF
Resources

Respimat how-to-use summary

Opens in new tab
SPIRIVA Respimat patient booklet for severe asthma Opens in new tab
Cover image of patient booklet 'A guide to using Spiriva Respimat (tiotropium) for severe asthma
Resources

SPIRIVA Respimat patient booklet for severe asthma

SPIRIVA Respimat patient booklet for severe asthma Opens in new tab
Cover image for 'Recognising and supporting patients with severe asthma' video
Video

Recognising and supporting patients with severe asthma

Cover image for 'How do we select the right inhaler' video
Video

How do we select the right inhaler?

Cover image for 'identifying severe asthma in primary care' video
Video

Asthma in primary care

The wider benefits of the Respimat inhaler Opens in new tab
Cover for infographic 'The wider benefits of the Respimat inhaler'
Infographic

The wider benefits of the Respimat inhaler

The wider benefits of the Respimat inhaler Opens in new tab
The environmental impact of inhalers Opens in new tab
Cover for infographic 'The environmental impact of inhalers'
Infographic

The environmental impact of inhalers

The environmental impact of inhalers Opens in new tab
 
 
 
 
 

PC-GB-110744 V2 June 2025

Reporting adverse events

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone).

Please be aware that this website contains promotional information about Boehringer Ingelheim medicines and services. Some of this may not be directly relevant to your scope of practice and it is your own decision whether you choose to view this information.

  1. Home
  2. Respiratory hub
  3. Respiratory
Boehringer Ingelheim
BI LOGO
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Sitemap
  • Terms of Use
  • Accessibility Statement

This information is for UK Healthcare Professionals only. Products discussed herein may have different labelling in different countries. 
Use of this site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Notice.

Copyright © 2021-2025 Boehringer Ingelheim, Inc. All rights reserved. PC-GB-110791 December 2024.